- Home
- UAC vs EQ Comparison
UAC vs EQ Comparison
Compare UAC & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UAC | EQ |
|---|---|---|
| Founded | 2025 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.6M | 140.1M |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | UAC | EQ |
|---|---|---|
| Price | $10.01 | $1.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $8.56 |
| AVG Volume (30 Days) | 186.7K | ★ 499.7K |
| Earning Date | N/A | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $41,095,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.51 | $0.76 |
| 52 Week High | $10.00 | $3.54 |
Technical Indicators
Market Signals| Indicator | UAC | EQ |
|---|---|---|
| Relative Strength Index (RSI) | 63.50 | 29.90 |
| Support Level | $9.51 | $1.05 |
| Resistance Level | N/A | $1.71 |
| Average True Range (ATR) | 0.01 | 0.12 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 100.00 | 0.00 |
Price Performance
Historical ComparisonAbout EQ Equillium Inc.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.